Similarly, high on-treatment platelet reactivity (alternatively called resistance) in patients taking clopidogrel due to the presence of the CYP2C19 loss-of-function allele is associated with a failure for this antiplatelet to add to aspirin in preventing recurrence after minor stroke and TIA [40]. Here, CYP2C19 is linked to stroke disorder.